Combined historical and electrocardiographic timing of acute anterior and inferior myocardial infarcts for prediction of reperfusion achievable size limitation

American Journal of Cardiology

Volumn 83, Issue 6, 1999, Pages 826-831

  Corey, Kathleen E ^a   Maynard, Charles ^b   Pahlm, Olle ^a   Wilkins, Michelle L ^a   Anderson, Stanley T ^a   Cerqueira, Manuel D ^b   Pryor, Aurora D ^a   Raitt, Merritt H ^b   Selvester, Ronald H Startt ^a   Turner, John ^a   Weaver, W Douglas ^b   Wagner, Galen S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ARTICLE; DIAGNOSTIC VALUE; ELECTROCARDIOGRAM; HEART INFARCTION SIZE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; ONSET AGE; PRIORITY JOURNAL; SCORING SYSTEM; STATISTICAL ANALYSIS;

ELECTROCARDIOGRAPHY; HEART; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCARDIUM; RANDOMIZED CONTROLLED TRIALS; STREPTOKINASE; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0033002574     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)01042-X     Document Type: Article

References (23)

1. Weaver W.D., Cerqueira M., Hallstrom A.P., Litwin P.E., Martin J.S., Kudenchuk P.J., Eisenberg M. Prehospital-initiated vs. hospital-initiated thrombolytic therapy. JAMA. 270:1993;1211-1216.
2. Rawles J. Halving of mortality at 1 year by domicilary thrombolysis in the Grampian Region Early Antistreplase Trial (GREAT). J Am Coll Cardiol. 23:1994;1-5.
3. Indication for fibrinolytic therapy in suspected acute myocardial infarction collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients . Lancet. 343:1994;311-322.
4. Maynard C., Weaver W.D. Streamlining the triage system for acute myocardial infarction. Cardiology Clinics. 13:1995;311-320.
5. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet. 1:1986;397.
6. Grines C.L., DeMaria A.N. Optimal utilization of thrombolytic therapy for acute myocardial infarction concepts and controversies . J Am Coll Cardiol. 16:1990;223-231.
7. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 329:1993;673-682.
8. Raitt M.H., Maynard C., Wagner G.S., Cerqueira M.D., Selvester R.H., Weaver W.D. Relation between symptom duration before thrombolytic therapy and final myocardial infarct size. Circulation. 93:1996;48-53.
9. Hackett D., Davies G., Chierehia S., Maseri A. Intermittent coronary occlusions in acute myocardial infarction value of combined thrombolytic and vasodilator therapy . N Engl J Med. 317:1987;1055-1059.
10. Hecht H.S., Shaw R.E., Bruse T., Myler R.K. Silent ischemia evaluation by tomographic thallium-201 exercise and redistribution myocardial imaging . J Am Coll Cardiol. 14:1989;895-900.
11. Anderson S.T., Wilkins M.L., Weaver W.D., Selvester R.H., Wagner G.S. Electrocardiographic phasing of acute myocardial infarction. J Electrocardiol. 25:1992;3-5.
12. Wilkins M.L., Pryor A.D., Maynard C., Wagner N.B., Elias W.J., Litwin P.E., Pahlm O., Selvester R.H., Weaver W.D., Wagner G.S., Anderson S.T. An electrocardiographic method for identifying and quantifying the acuteness of myocardial ischemia/infarction to guide decisions regarding reperfusion therapy. Am J Cardiol. 75:1995;617-620.
13. Kennedy J.W., Ritchie J.L., Davis K.B., Fritz J.K. Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. N Engl J Med. 309:1983;1477-1482.
14. Kennedy J.W., Martin G.V., Davis K.B., Maynard C., Stadius M.L., Sheehan F.H., Ritchie J.L. The western Washington intravenous streptokinase in acute myocardial infarction randomized trial. Circulation. 77:1988;345-352.
15. Althouse R., Maynard C., Cerqueira M., Olsufka M., Ritchie J.L., Kennedy J.W. The western Washington myocardial infarction registry and emergency department tissue plasminogen activator treatment trial. Am J Cardiol. 66:1990;1298-1303.
16. Aldrich H.R., Hindman N.B., Hinohara T., Jones M.G., Boswick J., Lee K.L., Bride W., Califf R.M., Wagner G.S. Identification of the optimal electrocardiograaphic leads for detecting acute epicardial injury in acute myocardial infarction. Am J Cardiol. 59:1987;20-23.
17. Hindman N.B., Schocken D.D., Widmann M., Anderson W.D., White R.D., Leggett S. Evaluation of a QRS scoring system for estimating myocardial infarct size. V. Specificity and method application of the complete system. Am J Cardiol. 55:1985;1485-1690.
18. Gambill C.L., Wilkins M.L., Haisty W.K., Anderson S.T., Wagner N.B., Startt Selvester R.H., Wagner G.S. T wave amplitudes in normal populations variation with electrocardiographic lead, gender, and age . J Electrocardiol. 28:1995;191-197.
19. Cerqueira M.D., Maynard C., Ritchie J.L. Radionuclide assessment of infarct size and left ventricular function in clinical trials of thrombolysis. Circulation. 84:1991;I-100-I-108.
20. Christian T.F., Schwartz R.S., Gibbons R.J. Determinants of infarcts size in reperfusion therapy for acute myocardial infarction. Circulation. 86:1992;81-90.
21. Christian T.F., Gibbons R.J., Clements I.P., Berger P.B., Selvester R.H., Wagner G.S. Estimates of myocardium at risk and collateral flow in acute myocardial infarction using electrocardiographic indexes with comparison to radionuclide and angiographic methods. J Am Coll Cardiol. 26:1995;388-393.
22. Anderson S.T., Pahlm O., Selvester R.H., Bailey J.J., Berson A.S., Barold S.S., Dower G.B., Clemmensen P., Elko P.P., Galen P., et al. A panoramic display of the orderly sequenced twelve lead electrocardiogram. J Electrocardiol. 27:1994;347-352.
23. Corr P.B., Gillis R.A. Role of the vagus nerves in the cardiovascular changes induced by coronary occlusion. Circulation. 49:1978;86-94.